Showing results (21-30 of 67) with videos related to

Sort By:
Pageof 7
Applied Biochemistry and Biotechnology|August 30, 2018
Probing Gallate-Mediated Selectivity and High-Affinity Binding of Epigallocatechin Gallate: a Way-Forward in the Design of Selective Inhibitors for Anti-apoptotic Bcl-2 ProteinsFisayo A Olotu, Clement Agoni, Emmanuel Adeniji, et al.
Chemistry & Biodiversity|October 8, 2019
CF3 -Pyridinyl Substitution on Antimalarial Therapeutics: Probing Differential Ligand Binding and Dynamical Inhibitory Effects of a Novel Triazolopyrimidine-Based Inhibitor on Plasmodium falciparum Dihydroorotate DehydrogenaseClement Agoni, Elliasu Y Salifu, Geraldene Munsamy, et al.
The Protein Journal|September 30, 2021
Glioma-Targeted Therapeutics: Computer-Aided Drug Design ProspectivePreantha Poonan, Clement Agoni, Mahmoud A A Ibrahim, et al.
Biotechnology Letters|November 1, 2018
Microbes, not humans: exploring the molecular basis of Pseudouridimycin selectivity towards bacterial and not human RNA polymeraseAli H Rabbad, Clement Agoni, Fisayo A Olotu, et al.
Cell Biochemistry and Biophysics|October 15, 2020
Molecular Basis of P131 Cryptosporidial-IMPDH Selectivity-A Structural, Dynamical and Mechanistic StanceKehinde F Omolabi, Clement Agoni, Fisayo A Olotu, et al.
Anti-Cancer Agents in Medicinal Chemistry|April 6, 2019
Turning to Computer-aided Drug Design in the Treatment of Diffuse Large B-cell Lymphoma: Has it been Helpful?Aimen K Aljoundi, Clement Agoni, Fisayo A Olotu, et al.
South African Journal of Botany : Official Journal of the South African Association of Botanists = Suid-Afrikaanse Tydskrif Vir Plantkunde : Amptelike Tydskrif Van Die Suid-Afrikaanse Genootskap Van Plantkundiges|August 26, 2020
Identification of potential SARS-CoV-2 inhibitors from South African medicinal plant extracts using molecular modelling approachesDepika Dwarka, Clement Agoni, John Jason Mellem, et al.
Chemistry & Biodiversity|December 22, 2021
Dual-Inhibition of Human N-Myristoyltransferase Subtypes Halts Common Cold Pathogenesis: Atomistic Perspectives from the Case of IMP-1088Clement Agoni, Elliasu Y Salifu, Gill Enslin, et al.
Current Pharmaceutical Biotechnology|November 19, 2019
Tweaking α -Galactoceramides: Probing the Dynamical Mechanisms of Improved Recognition for Invariant Natural Killer T-cell Receptor in Cancer ImmunotherapeuticsHouda Washah, Clement Agoni, Fisayo A Olotu, et al.
Computational Biology and Chemistry|January 26, 2020
Triple Mycobacterial ATP-synthase mutations impedes Bedaquiline binding: Atomistic and structural perspectivesElliasu Y Salifu, Clement Agoni, Fisayo A Olotu, et al.
Pageof 7